Results 231 to 240 of about 882,069 (246)
Some of the next articles are maybe not open access.
Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors
Gynecologic Oncology, 2000The goals of this study were to analyze preoperative serum levels of CA 125, carcinoembryonic antigen (CEA), and CA 19-9 in patients with borderline ovarian tumors and to investigate if routine assessment of these markers in follow-up may lead to earlier detection of recurrence.For patient identification a database was used, in which data from all ...
Engelen, MJA +6 more
openaire +3 more sources
The clinical utility of the CA 19-9 tumor-associated antigen.
The American journal of gastroenterology, 1990Since Koprowski and coworkers discovered the CA 19-9 antigen 10 yr ago, it has become the most useful blood test in the diagnosis and management of patients with cancer of the pancreas. With an upper limit of normal of 37 U/ml, the assay's overall sensitivity is approximately 80% and its specificity is 90%.
openaire +1 more source
Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma, 1986
CA 19-9, a new antigenic tumor marker for gastrointestinal tumors, has been assayed with Carcinoembriogenic antigen, in 90 healthy patients and 47 patients with gastric cancer (20) and colorectal cancer (27). A good specificity has been found for this antigen (97.7%). Its sensibility seems to be slightly superior to that of CEA. However the sensibility
E, Capocasale +4 more
openaire +1 more source
CA 19-9, a new antigenic tumor marker for gastrointestinal tumors, has been assayed with Carcinoembriogenic antigen, in 90 healthy patients and 47 patients with gastric cancer (20) and colorectal cancer (27). A good specificity has been found for this antigen (97.7%). Its sensibility seems to be slightly superior to that of CEA. However the sensibility
E, Capocasale +4 more
openaire +1 more source
[Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002carcinoembryonic antigen (CEA) was first described more than three decades ago, when its presence was demonstrated in fetal gut tissue and in tumors from gastrointestinal tract. Subsequently, CEA was detected in the circulation of patients and recognized as a serum marker for colorectal cancer.
openaire +1 more source
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1996
L, Fernández-Fernández +4 more
openaire +2 more sources
L, Fernández-Fernández +4 more
openaire +2 more sources
Annales chirurgiae et gynaecologiae, 1987
The concentrations of carcinoembryonic antigen (CEA) and the gastrointestinal cancer associated antigen CA 19-9 were studied by radioimmunoassay in serum samples from patients with malignant and benign pulmonary tumours. Elevated levels of either markers were found in 14% of patients with malignant tumours and in none of the cases with benign lesions ...
L, Heikkilä +5 more
openaire +1 more source
The concentrations of carcinoembryonic antigen (CEA) and the gastrointestinal cancer associated antigen CA 19-9 were studied by radioimmunoassay in serum samples from patients with malignant and benign pulmonary tumours. Elevated levels of either markers were found in 14% of patients with malignant tumours and in none of the cases with benign lesions ...
L, Heikkilä +5 more
openaire +1 more source
CA 19-9 and Lewis Antigens in Pancreatic Cancer
Journal of Clinical Oncology, 2009openaire +2 more sources
[Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma].
Gastroenterologie clinique et biologique, 1998The value of serum Ca 19-9 dosage for pancreatic carcinoma diagnosis has been studied in heterogeneous series. The effect of the complications of chronic pancreatitis and pancreatic carcinoma on serum Ca 19-9 value has not been assessed precisely. The aims of this study were to assess: a) the value of Ca 19-9 to differentiate benign from malignant ...
A, Nouts +3 more
openaire +1 more source
[Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
Gan to kagaku ryoho. Cancer & chemotherapy, 1986The levels of the serum carbohydrate antigen (CA) 19-9 were assayed in 284 cases including 77 patients with gastric cancer. The CA 19-9 levels were positive in 38% of gastric cancer cases, and they were significantly higher than those of benign gastric diseases.
K, Nishida +7 more
openaire +1 more source